Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 15, 2024

https://www.globenewswire.com/news-release/2024/05/15/2882866/0/en/Mereo-BioPharma-Reports-First-Quarter-2024-Financial-Results-and-Provides-Corporate-Update.html

LONDON, May 15, 2024 (GLOBE NEWSWIRE) — Mereo BioPharma Group plc (NASDAQ:MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced its financial results for the first quarter ended March 31, 2024, and provided an update on recent corporate highlights. The Company reported cash and cash equivalents of $48.7 million as of March 31, 2024 and continues to expect this to fund its operations into 2026.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.